Stay updated on REMNANT Study: MRD Negativity Relapse Clinical Trial
Sign up to get notified when there's something new on the REMNANT Study: MRD Negativity Relapse Clinical Trial page.

Latest updates to the REMNANT Study: MRD Negativity Relapse Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.3.3 was added. HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.2%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check42 days agoChange DetectedRevision: v3.3.2 was added, replacing v3.2.0; this is a minor platform update with no impact on study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check49 days agoChange DetectedThe government funding lapse notice banner and related operating-status messaging were removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check63 days agoChange DetectedVersion history shows recruitment/status updates in versions 2–4 and a study identification update in version 5 for the REMNANT study (NCT04513639). These entries reflect the trial’s current status and identifying details as recorded on ClinicalTrials.gov.SummaryDifference0.1%

- Check92 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference13%

- Check99 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.SummaryDifference0.3%

Stay in the know with updates to REMNANT Study: MRD Negativity Relapse Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REMNANT Study: MRD Negativity Relapse Clinical Trial page.